CXDO vs REGN · P/E 54, rev $60.8M vs P/E 14, rev $14.34B
Crexendo Inc (CXDO) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Crexendo Inc (CXDO) is a telecom services company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported CXDO revenue for 2024-12-31 was $60.8M. Net income was $507.0K. Revenue was up 329.5% from 2023-12-31 to 2024-12-31. CXDO currently screens at market cap $245.4M and trailing P/E 54.1.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
CXDO currently screens at market cap $245.4M and trailing P/E 54.1. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the CXDO and REGN stock pages for the full models.
Not investment advice.